Regarding CXCL13 measurement in CSF, it seems to be an effective parameter reflecting the inflammatory intrathecal B cell response and may be suggested to take part in the diagnostic but mainly the prognostic investigation in MS disease. This evidence concerns the gene CXCL13 and myeloid sarcoma.